A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene ( LDH , encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two proline residues (P402/ P564) located in the LXXLAP amino acid motif in the ODDD of HIF-1α were found to be good substrates for the action of a group of enzymes called prolyl-4-hydroxylases (PHDs) or HIF-1 prolyl hydroxylases (HPH)22, 28.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [22]
In the citing paper
“Oxygen sensing is mediated primarily by prolyl hydroxylase domain-containing proteins (PHDs), iron- and ascorbate-dependent enzymes in the 2-oxoglutarate (2-OG)–dependent dioxygenase family”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“These enzymes are essential for repressing HIF signaling in an oxygen-dependent manner [42,43]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“Under normoxic conditions, prolyl hydroxylase enzymes (EGLN 1–3, also known as PHD 1–3) use oxygen as a substrate to hydroxylate key proline residues within the HIF-1 and HIF-2 α subunits”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
In the citing paper
“Hypoxia activates HIF signaling by promoting the protein stability of HIF-α subunits.”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Cited by
Items 401–500 of 1,022
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0190-2 · Cited by 166
“Antioxidant response from junD in Ki-Ras transformed fibroblast cells have been reported to reduce HIF expression and angiogenesis by enhancing PHDs expression [35].”
BackgroundInfluentialGene regulation by hypoxia and the neurodevelopmental origin of schizophrenia
Schmidt‐Kastner, R., van Os, J., Steinbusch, H. W. M., & Schmitz, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.022 · Cited by 169
Xue, J., Li, X., Jiao, S., Wei, Y., Wu, G., & Fang, J. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.049 · Cited by 169
Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hütter, J., Schramm, M., & Flamme, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00862-8 · Cited by 165
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.05.002 · Cited by 165
“In order to be active, PHDs require O2, the citric acid cycle intermediate 2OG as a co-substrate, plus Fe(II) and ascorbate as cofactors [14,15].”
BackgroundMizukami, Y., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., & Chung, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3017 · Cited by 165
“There are two consensus HREs at 975 bp (5 -TACGTGGG) and 306 bp (5 -TACGTGCG) in the VEGF promoter (8).”
BackgroundInfluentialHypoxia-induced Angiogenesis during Carcinogenesis
Choe, G.-S., Bae, M.-G., Jeong, J.-W., Mun, H.-E., & Kim, G.-W. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.120 · Cited by 165
Nitric oxide signaling in hypoxia
Ho, J. J. D., Man, H. S. J., & Marsden, P. A. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0880-5 · Cited by 167
“The first is the enzyme HIF prolyl-4hydoxylases, also known as prolyl hydroxylase domaincontaining proteins (PHDs), of which there are three isoforms (PHD1, 2, and 3) [47, 48].”
BackgroundHypoxia-inducible factor (HIF) in human tumorigenesis.
Mabjeesh, N. J., & Amir, S. (2007) · PubMed · doi:10.14670/hh-22.559 · Cited by 141
Laemmle, A., Lechleiter, A., Roh, V., Schwarz, C., Portmann, S., Furer, C., Keogh, A., Tschan, M. P., Candinas, D., Vorburger, S. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033433 · Cited by 153
“Specific prolyl hydroxylases (PHD), which depend on the substrates oxygen, Fe (II) and 2-oxoglutarate, target the a-subunit under normoxic conditions [30].”
BackgroundDrappier, J., Thibon, C., Rabot, A., & Geny-Denis, L. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1355776 · Cited by 164
The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF)
Ozer, A., Wu, L. C., & Bruick, R. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502716102 · Cited by 164
Self-citationBurr, S. P., Costa, A. S. H., Grice, G. L., Timms, R. T., Lobb, I. T., Freisinger, P., Dodd, R. B., Dougan, G., Lehner, P. J., Frezza, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.015 · Cited by 164
Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species
Vieira, H. L. A., Alves, P. M., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.007 · Cited by 164
“Importantly, ROS generation is also associated with the cellular response against hypoxia where ROS can activate/stabilize HIF, probably through the action of prolyl hydroxylases (Bruick and McKnight, 2001; Klimova and Chandel, 2008; Yuan et al., 2008).”
BackgroundHypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish
Thompson, A. A. R., Elks, P. M., Marriott, H. M., Eamsamarng, S., Higgins, K. R., Lewis, A., Williams, L., Parmar, S., Shaw, G., McGrath, E. E., et al. (2014) · Blood · doi:10.1182/blood-2013-05-500207 · Cited by 149
Inflammation in the vascular bed: Importance of vitamin C
Aguirre, R., & May, J. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.002 · Cited by 166
“Perhaps best known of these are the prolyl and lysyl hydroxylases that catalyze hydroxylation of hypoxia-inducible factor-1α (Bruick & McKnight, 2001) and procollagen (Myllylä et al., 1984).”
BackgroundOkuyama, H., Krishnamachary, B., Zhou, Y. F., Nagasawa, H., Bosch-Marce, M., & Semenza, G. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602003200 · Cited by 151
Kuiper, C., & Vissers, M. C. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00359 · Cited by 163
“HIF-1α protein is constantly synthesized in most cells in the body, and under normal, physiological conditions is rapidly degraded (24) following hydroxylation of proline residues 402 and 564 by prolyl-hydroxylases (PHD) 1–3 (25, 26) (Table 1).”
BackgroundRabinowitz, M. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400386j · Cited by 163
Speer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 155
“Under normoxic conditions, PHDs hydroxylate P564 on HIF-1a, allowing the domain to be recognized by Von Hippel-Lindau (VHL) protein, an E3 ubiquitin ligase, and thereby targeted for degradation by the 26s proteasome [14–16].”
BackgroundThe HIF pathway as a therapeutic target
Hewitson, K. S., & Schofield, C. J. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03202-7 · Cited by 163
RACK1 vs. HSP90: Competition for HIF-1α Degradation vs. Stabilization
Liu, Y. V., & Semenza, G. L. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3981 · Cited by 162
Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting
Persano, L., Rampazzo, E., Basso, G., & Viola, G. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.001 · Cited by 162
Oxygen tension regulates the expression of a group of procollagen hydroxylases
Hofbauer, K., Gess, B., Lohaus, C., Meyer, H. E., Katschinski, D., & Kurtz, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03846.x · Cited by 162
Shin, D. H., Chun, Y.-S., Lee, D. S., Huang, L. E., & Park, J.-W. (2008) · Blood · doi:10.1182/blood-2007-11-120576 · Cited by 162
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo
Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R., & Kaelin, W. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-09 · Cited by 161
Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer
Kaelin, W. G. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162480 · Cited by 161
Advances in stem cell mobilization
Hopman, R. K., & DiPersio, J. F. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.01.001 · Cited by 161
Choi, Y. K., Kim, C.-K., Lee, H., Jeoung, D., Ha, K.-S., Kwon, Y.-G., Kim, K.-W., & Kim, Y.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131284 · Cited by 161
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin
Sánchez, A. B., Calpena, A. C., & Clares, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816981 · Cited by 161
“Pharmacologic concentrations of MLT inhibit angiogenesis by suppressing VEGF mRNA and VEGF protein induced by the hypoxia mimetic CoCl2 in all three human cancer cell lines.”
BackgroundInfluentialHIF-1 and hypoxic response: the plot thickens
Poellinger, L., & Johnson, R. S. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.006 · Cited by 161
Mack, F. A., Rathmell, W. K., Arsham, A. M., Gnarra, J., Keith, B., & Simon, M. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00240-4 · Cited by 160
“All three elements of this pathway are conserved in C. elegans, Drosophila and mammals (Bruick and McKnight 2001; Epstein et al. 2001).”
BackgroundHuman Genetic Adaptation to High Altitude: Evidence from the Andes
Julian, C. G., & Moore, L. G. (2019) · Genes · doi:10.3390/genes10020150 · Cited by 160
“In normoxia, O2-dependent negative regulators of HIF called prolyl hydroxylases (PHDs) enable the hydroxylation of proline residues of HIF1/2α subunits [67]; this promotes the binding of von Hippel–Lindau tumor suppressor (vHL) protein and, subsequently, degrades the HIF1/2α [68,69].”
BackgroundAdvances in stem cell mobilization
Motabi, I. H., & DiPersio, J. F. (2012) · Blood Reviews · doi:10.1016/j.blre.2012.09.003 · Cited by 160
“ubiquitination, preventing the formation of an active transcription factor [152,153].”
BackgroundHypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer
Chipurupalli, S., Kannan, E., Tergaonkar, V., D’Andrea, R. J., & Robinson, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030749 · Cited by 164
“PHDs are dioxygenases that require molecular oxygen, Fe2+, and 2-oxoglutarate as substrates [38].”
BackgroundSecond‐Coordination Sphere Effects on Selectivity and Specificity of Heme and Nonheme Iron Enzymes
de Visser, S. P. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905119 · Cited by 161
Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis
McColl, B., Stacker, S. A., & Achen, M. G. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11207-0807.x · Cited by 164
“467 lysed by a family of three prolyl hydroxylases utilising molecular oxygen as a substrate (103).”
MethodHypoxia, HIFs and bone development
Araldi, E., & Schipani, E. (2010) · Bone · doi:10.1016/j.bone.2010.04.606 · Cited by 148
“In particular, a family of HIF prolyl 4-hydroxylases is responsible for the hydroxylation of two proline residues (P402 and P564) in the oxygen dependent degradation domain (ODDD) of HIF-1 [6].”
BackgroundPGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types
Rasbach, K. A., Gupta, R. K., Ruas, J. L., Wu, J., Naseri, E., Estall, J. L., & Spiegelman, B. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016089107 · Cited by 145
Hypoxia-inducible factors and diabetes
Gunton, J. E. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137556 · Cited by 159
“With its critical role in oxygen sensing and hypoxia responses, it is not surprising that HIF-1α is regulated by many factors (22-29).”
BackgroundThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
Tal, R., & Segars, J. H. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt042 · Cited by 159
“…between the tumor suppressor Von-Hippel– Lindau (VHL) and HIF-1a is enabled by two prolyl hydroxylations within the HIF-1a degradation domain, at residues P402 and P564 by prolyl hydroxylases (PHDs; Bruick and McKnight, 2001; Epstein et al., 2001; Jaakkola et al., 2001; Masson et al., 2001).”
BackgroundBento, C. F., & Pereira, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2191-8 · Cited by 159
Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells
Makino, Y., Nakamura, H., Ikeda, E., Ohnuma, K., Yamauchi, K., Yabe, Y., Poellinger, L., Okada, Y., Morimoto, C., & Tanaka, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6534 · Cited by 159
Chen, H., Giri, N. C., Zhang, R., Yamane, K., Zhang, Y., Maroney, M., & Costa, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058503 · Cited by 145
Regulation of angiogenesis by oxygen sensing mechanisms
Fong, G. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0458-z · Cited by 160
Persistent induction of HIF‐1α and ‐2α in cardiomyocytes and stromal cells of ischemic myocardium
Jürgensen, J. S., Rosenberger, C., Wiesener, M. S., Warnecke, C., Hörstrup, J. H., Gräfe, M., Philipp, S., Griethe, W., Maxwell, P. H., Frei, U., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1605fje · Cited by 129
Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor
McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicaël, C. A., Chen, Q.-Y., Banerji, B., Hewitson, K. S., & Schofield, C. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050841b · Cited by 147
New anticancer strategies targeting HIF-1
Yeo, E.-J., Chun, Y.-S., & Park, J.-W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.040 · Cited by 158
Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression
Huang, E. L., Bindra, R. S., Glazer, P. M., & Harris, A. L. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0133-6 · Cited by 159
Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang, Y., Lin, D., & Taniguchi, C. M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9178-y · Cited by 142
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M
Abe, H., Takeda, N., Isagawa, T., Semba, H., Nishimura, S., Morioka, M. S., Nakagama, Y., Sato, T., Soma, K., Koyama, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10859-w · Cited by 148
How oxygen makes its presence felt: Figure 1.
Kaelin, W. G. (2002) · Genes & Development · doi:10.1101/gad.1003602 · Cited by 150
Apoptotic Cell Death Under Hypoxia
Sendoel, A., & Hengartner, M. O. (2014) · Physiology · doi:10.1152/physiol.00016.2013 · Cited by 157
Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer
Lundgren, K., Holm, C., & Landberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7390-6 · Cited by 159
Roles of Reactive Oxygen Species in the Fate of Stem Cells
Chaudhari, P., Ye, Z., & Jang, Y.-Y. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4963 · Cited by 146
Helix–loop–helix proteins and the advent of cellular diversity: 30 years of discovery
Murre, C. (2019) · Genes & Development · doi:10.1101/gad.320663.118 · Cited by 159
Knowles, H. J., Tian, Y.-M., Mole, D. R., & Harris, A. L. (2004) · Circulation Research · doi:10.1161/01.res.0000134924.89412.70 · Cited by 143
Oxygen‐dependent regulation of hypoxia‐inducible factors by prolyl and asparaginyl hydroxylation
Lando, D., Gorman, J. J., Whitelaw, M. L., & Peet, D. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03445.x · Cited by 137
Vadlapatla, R. K., Vadlapudi, A. D., & Mitra, A. K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990015 · Cited by 157
“Ascorbate plays a very important role in regulating the activity of PHDs and maintaining the Fe2+ state of iron [35].”
BackgroundOxygen Sensing Gets a Second Wind
Bruick, R. K., & McKnight, S. L. (2002) · Science · doi:10.1126/science.1069825 · Cited by 143
Self-citationPHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
German, N. J., Yoon, H., Yusuf, R. Z., Murphy, J. P., Finley, L. W. S., Laurent, G., Haas, W., Satterstrom, F. K., Guarnerio, J., Zaganjor, E., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.014 · Cited by 156
Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner
Chen, R., Dioum, E. M., Hogg, R. T., Gerard, R. D., & Garcia, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175414 · Cited by 155
Pistollato, F., Rampazzo, E., Persano, L., Abbadi, S., Frasson, C., Denaro, L., D'Avella, D., Panchision, D. M., Puppa, A. D., Scienza, R., et al. (2010) · Stem Cells · doi:10.1002/stem.518 · Cited by 148
Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies
Olson, K. A., Schell, J. C., & Rutter, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.002 · Cited by 154
“Under conditions of normoxia, HIF activity is very low because the / subunits are rapidly degraded by the process of oxygen-dependent prolyl hydroxylation, binding of von Hippel– Lindau factor (VHL), E3 ubiquitin ligation, and proteasomal degradation [88,89].”
Pasanen, A., Heikkilä, M. M., Rautavuoma, K., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.008 · Cited by 156
Physiology and pathophysiology of renal erythropoietin-producing cells
Shih, H., Wu, C., & Lin, S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.03.017 · Cited by 154
The role of hypoxia-inducible factors in cancer
Maynard, M. A., & Ohh, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7082-2 · Cited by 154
Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy
Bekeredjian, R., Walton, C. B., MacCannell, K. A., Ecker, J., Kruse, F., Outten, J. T., Sutcliffe, D., Gerard, R. D., Bruick, R. K., & Shohet, R. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011693 · Cited by 136
“[4], are hydroxylated by specific prolyl hydroxylases [5–8].”
BackgroundSelf-citationOn the Origin of Tibetans and Their Genetic Basis in Adapting High-Altitude Environments
Wang, B., Zhang, Y.-B., Zhang, F., Lin, H., Wang, X., Wan, N., Ye, Z., Weng, H., Zhang, L., Li, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017002 · Cited by 149
“Another candidate gene under positive selection was EGLN1/ PHD2, which is a member of the 2-oxoglutarate-dependent dioxygenase superfamily and a sensor for low oxygen levels [35].”
Backgroundp300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1)
SCHMID, T., ZHOU, J., KÖHL, R., & BRÜNE, B. (2004) · Biochemical Journal · doi:10.1042/bj20031299 · Cited by 138
Erythropoiesis‐stimulating agents and other methods to enhance oxygen transport
Elliott, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.89 · Cited by 126
“An O2dependent enzyme, (HIF-prolyl hydroxylase; HIF-PH) hydroxylates HIF at specific prolines contained in O2 degradation domains (Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 2001; Masson et al., 2001).”
BackgroundIDH mutations in acute myeloid leukemia
Rakheja, D., Konoplev, S. N., Medeiros, L. J., & Chen, W. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.05.003 · Cited by 154
The VHL tumor suppressor and HIF: insights from genetic studies in mice
Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402313 · Cited by 151
Prolyl and lysyl hydroxylases in collagen synthesis
Salo, A. M., & Myllyharju, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14197 · Cited by 151
Flashman, E., Davies, S. L., Yeoh, K. K., & Schofield, C. J. (2010) · Biochemical Journal · doi:10.1042/bj20091609 · Cited by 129
Joo, H.-Y., Yun, M., Jeong, J., Park, E., Shin, H.-J., Woo, S. R., Jung, J. K., Kim, Y. M., Park, J., Kim, J., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.119 · Cited by 150
Centanin, L., Dekanty, A., Romero, N. M., Irisarri, M., Gorr, T. A., & Wappner, P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.020 · Cited by 151
“Hydroxylation is mediated by 2-oxoglutarate/iron(II)-dependent prolyl-4-hydroxylases, which use dioxygen as a cosubstrate for catalysis and, hence, are considered to be bona fide oxygen sensors (Bruick and McKnight, 2001; Epstein et al., 2001).”
BackgroundKrebs, C., Price, J. C., Baldwin, J., Saleh, L., Green, M. T., & Bollinger, J. M., Jr. (2005) · Inorganic Chemistry · doi:10.1021/ic048523l · Cited by 150
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Ghosh, A. K., Shanafelt, T. D., Cimmino, A., Taccioli, C., Volinia, S., Liu, C.-G., Calin, G. A., Croce, C. M., Chan, D. A., Giaccia, A. J., et al. (2009) · Blood · doi:10.1182/blood-2008-10-185686 · Cited by 137
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 136
Nikinmaa, M. (2002) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(02)00132-0 · Cited by 149
Kondo, S., Seo, S. Y., Yoshizaki, T., Wakisaka, N., Furukawa, M., Joab, I., Jang, K. L., & Pagano, J. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1679 · Cited by 142
“The oxygen-dependent turnover of HIF1a protein is regulated by four isoforms of prolyl HIF-hydroxylases (PHD), termed PHD1-4, that modify HIF1a by hydroxylation at two conserved proline residues located in the oxygen-dependent degradation domain of the protein (13, 14).”
BackgroundHIF-1: An Oxygen Response System with Special Relevance to the Kidney
Maxwell, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092792.97122.e0 · Cited by 132
“Alternative names are HIF-PH 1 to 3 (for HIF prolyl hydroxylase) and EGLN 1 to 3 (for homologues of egl9) (39,40).”
BackgroundMicroRNAs: New Players in Cardiac Injury and Protection
Kukreja, R. C., Yin, C., & Salloum, F. N. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073528 · Cited by 148
The Genomics and Genetics of Oxygen Homeostasis
Semenza, G. L. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111119-073356 · Cited by 135
“Three prolyl hydroxylase domain (PHD) proteins (PHD1–3) mediatingHIF prolyl hydroxylation have been identified in mammals (10, 23).”
BackgroundSanjuán-Pla, A., Cervera, A. M., Apostolova, N., Garcia-Bou, R., Víctor, V. M., Murphy, M. P., & McCreath, K. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.088 · Cited by 135
“sequent proteosomal degradation following hydroxylation of proline [4,5] and asparagine residues [6].”
BackgroundTrentin, D., Hall, H., Wechsler, S., & Hubbell, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505964102 · Cited by 148
Role of hypoxia-inducible factor-1α as a cancer therapy target
Patiar, S., & Harris, A. L. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01290 · Cited by 125
The magic of the hypoxia-signaling cascade
Benizri, E. I., Ginouvès, A., & Berra, E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7472-0 · Cited by 149
Elks, P. M., Brizee, S., van der Vaart, M., Walmsley, S. R., van Eeden, F. J., Renshaw, S. A., & Meijer, A. H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003789 · Cited by 148
The role of oxygen in ruminant preimplantation embryo development and metabolism
Harvey, A. J. (2006) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2006.10.008 · Cited by 147
“HIF proteins are continuously synthesized but are rapidly degraded by a von Hippel Lindau protein (pVHL) mediated ubiquitin-proteasome system under high oxygen conditions (Bruick and McKnight, 2002; Lando et al., 2002), remaining stable only in cells cultured under low oxygen conditions (Fig.”
BackgroundTriantafyllou, A., Liakos, P., Tsakalof, A., Georgatsou, E., Simos, G., & Bonanou, S. (2006) · Free Radical Research · doi:10.1080/10715760600730810 · Cited by 120
Schneider, M. A., Geyte, K. V., Fraisl, P., Kiss, J., Aragonés, J., Mazzone, M., Mairbäurl, H., Bock, K. D., Jeoung, N. H., Mollenhauer, M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.057 · Cited by 147
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting
Bikfalvi, A., & Bicknell, R. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02109-0 · Cited by 146
Hieta, R., & Myllyharju, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201865200 · Cited by 146
Oxygen and Iron Regulation of Iron Regulatory Protein 2
Hanson, E. S., Rawlins, M. L., & Leibold, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302798200 · Cited by 141
2-Oxoglutarate analogue inhibitors of hif prolyl hydroxylase
Mole, D. R., Schlemminger, I., McNeill, L. A., Hewitson, K. S., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00539-0 · Cited by 145
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Chowdhury, R., Leung, I. K. H., Tian, Y.-M., Abboud, M. I., Ge, W., Domene, C., Cantrelle, F.-X., Landrieu, I., Hardy, A. P., Pugh, C. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms12673 · Cited by 145
COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
van de Sluis, B., Mao, X., Zhai, Y., Groot, A. J., Vermeulen, J. F., van der Wall, E., van Diest, P. J., Hofker, M. H., Wijmenga, C., Klomp, L. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40583 · Cited by 126
Lin, M., Chen, Y., Jin, J., Hu, Y., Zhou, K. K., Zhu, M., Le, Y.-Z., Ge, J., Johnson, R. S., & Ma, J.-X. (2011) · Diabetologia · doi:10.1007/s00125-011-2081-0 · Cited by 138
Metadata
- Authors
- Bruick, R. K., & McKnight, S. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- McKnight, Steven L.
- ORCID
- McKnight, Steven L.
- Venue
- Science
- Published
- 2001-11-09
- Volume
- 294
- Issue
- 5545
- Pages
- 1337-1340
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2042216712
- Cited by
- 2,549
- References
- 27
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 67 · 2023: 65 · 2022: 90 · 2021: 95 · 2020: 80 · 2019: 90 · 2018: 103 · 2017: 98 · 2016: 113 · 2015: 109 · 2014: 104 · 2013: 115 · 2012: 114
- FWCI
- 42.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- prolyl 4-hydroxylase, hypoxia-inducible factor, HIF-1α, oxygen sensing, proline hydroxylation, protein degradation, ubiquitin ligase, post-translational modification, lactate dehydrogenase, Drosophila melanogaster, normoxia
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Drosophila melanogaster, Humans, Hydroxylation, Hydroxyproline, L-Lactate Dehydrogenase, Molecular Sequence Data, Mutation, Nuclear Proteins, Oxygen, Procollagen-Proline Dioxygenase, Recombinant Proteins, RNA, Double-Stranded, Substrate Specificity, Transcription Factors, Transfection, Cell Hypoxia, Gene Expression Regulation, Enzymologic, Sequence Alignment, Conserved Sequence, Genes, Insect, Genes, Reporter, Amino Acid Substitution, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.